These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 12700694)
21. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Schmidt HD; Pierce RC Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308 [TBL] [Abstract][Full Text] [Related]
22. Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Heidbreder CA; Andreoli M; Marcon C; Hutcheson DM; Gardner EL; Ashby CR Addict Biol; 2007 Mar; 12(1):35-50. PubMed ID: 17407496 [TBL] [Abstract][Full Text] [Related]
23. The dopamine β-hydroxylase inhibitor, nepicastat, suppresses chocolate self-administration and reinstatement of chocolate seeking in rats. Zaru A; Maccioni P; Colombo G; Gessa GL Br J Nutr; 2013 Oct; 110(8):1524-33. PubMed ID: 23561307 [TBL] [Abstract][Full Text] [Related]
25. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. David V; Besson M; Changeux JP; Granon S; Cazala P Neuropharmacology; 2006 Jun; 50(8):1030-40. PubMed ID: 16580026 [TBL] [Abstract][Full Text] [Related]
26. Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cues. Guy EG; Choi E; Pratt WE Behav Brain Res; 2011 Jun; 219(2):265-72. PubMed ID: 21262268 [TBL] [Abstract][Full Text] [Related]
27. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking. Anderson SM; Schmidt HD; Pierce RC Neuropsychopharmacology; 2006 Jul; 31(7):1452-61. PubMed ID: 16205775 [TBL] [Abstract][Full Text] [Related]
29. The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. Vengeliene V; Leonardi-Essmann F; Perreau-Lenz S; Gebicke-Haerter P; Drescher K; Gross G; Spanagel R FASEB J; 2006 Nov; 20(13):2223-33. PubMed ID: 17077299 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the rat. Cervo L; Di Clemente A; Orrù A; Moro F; Cassina C; Pich EM; Corsi M; Gozzi A; Bifone A Addict Biol; 2013 Sep; 18(5):800-11. PubMed ID: 23490434 [TBL] [Abstract][Full Text] [Related]
31. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873 [TBL] [Abstract][Full Text] [Related]
33. Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain. Schwarz A; Gozzi A; Reese T; Bertani S; Crestan V; Hagan J; Heidbreder C; Bifone A Synapse; 2004 Oct; 54(1):1-10. PubMed ID: 15300879 [TBL] [Abstract][Full Text] [Related]
34. Differential role of N-methyl-D-aspartate receptor-mediated glutamate transmission in the nucleus accumbens shell and core in nicotine seeking in rats. D'Souza MS; Markou A Eur J Neurosci; 2014 Apr; 39(8):1314-22. PubMed ID: 24467279 [TBL] [Abstract][Full Text] [Related]
35. Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex. Lacroix LP; Hows ME; Shah AJ; Hagan JJ; Heidbreder CA Neuropsychopharmacology; 2003 May; 28(5):839-49. PubMed ID: 12637956 [TBL] [Abstract][Full Text] [Related]
36. Intravenous self-administration of nicotine is altered by lesions of the posterior, but not anterior, pedunculopontine tegmental nucleus. Alderson HL; Latimer MP; Winn P Eur J Neurosci; 2006 Apr; 23(8):2169-75. PubMed ID: 16630063 [TBL] [Abstract][Full Text] [Related]
37. Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders. Heidbreder C Naunyn Schmiedebergs Arch Pharmacol; 2013 Feb; 386(2):167-76. PubMed ID: 23104235 [TBL] [Abstract][Full Text] [Related]
38. Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Heidbreder CA; Newman AH Ann N Y Acad Sci; 2010 Feb; 1187():4-34. PubMed ID: 20201845 [TBL] [Abstract][Full Text] [Related]
39. Selective dopamine D3 receptor antagonists: a review 2001-2005. Micheli F; Heidbreder C Recent Pat CNS Drug Discov; 2006 Nov; 1(3):271-88. PubMed ID: 18221209 [TBL] [Abstract][Full Text] [Related]
40. The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity. Thanos PK; Michaelides M; Ho CW; Wang GJ; Newman AH; Heidbreder CA; Ashby CR; Gardner EL; Volkow ND Pharmacol Biochem Behav; 2008 Jun; 89(4):499-507. PubMed ID: 18329700 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]